Abstracts
3 June 2009

The scale of the problem

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
156
Views
179
Downloads

Authors

It is generally accepted that patients with active malignancy are prone to develop venous thromboembolic disease. Factors that are thought to contribute to the increased risk of venous thrombosis in these patients, include procoagulant effects of cancer cells themselves or caused by their interaction with the host environment, chemotherapeutic drugs, surgery and immobility.

Altmetrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

How to Cite